CompoundList
Sign in
Molecular formula

C19H21N7O2S

14 compounds have this formula on CompoundList.

Molar mass
411.48g/mol
Monoisotopic mass
411.1477Da
Atoms
50
Elements
5
Rings plus double bonds
13

The formula C19H21N7O2S describes a molecule made of 19 carbon atoms, 21 hydrogen atoms, 7 nitrogen atoms, 2 oxygen atoms and 1 sulfur atom. It is written in Hill notation: carbon first, then hydrogen, then the other elements in alphabetical order. The formula tells you which atoms are present, not how they are connected, which is why several different chemicals can share it.

Elemental composition

  • C Carbon × 1955.46%
    12.011 × 19 = 228.209 g/mol
  • H Hydrogen × 215.14%
    1.008 × 21 = 21.168 g/mol
  • N Nitrogen × 723.83%
    14.007 × 7 = 98.049 g/mol
  • O Oxygen × 27.78%
    15.999 × 2 = 31.998 g/mol
  • S Sulfur × 17.79%
    32.06 × 1 = 32.060 g/mol
Look up another formula

Compounds with the formula C19H21N7O2S

Isomers we list, best known first. Open one to see its structure, properties, safety data and suppliers.

Showing 1 to 14 of 14 compounds

GLS1 Inhibitor chemical structure, C19H21N7O2S, CAS 1832646-52-2
GLS1 Inhibitor
CAS 1832646-52-2C19H21N7O2S
7-(2-((1H-Benzo[d]imidazol-2-yl)thio)ethyl)-3-methyl-8-(pyrrolidin-1-yl)-1H-purine-2,6(3H,7H)-dione chemical structure, C19H21N7O2S, CAS 796879-64-6
7-(2-((1H-Benzo[d]imidazol-2-yl)thio)ethyl)-3-methyl-8-(pyrrolidin-1-yl)-1H-purine-2,6(3H,7H)-dione
CAS 796879-64-6C19H21N7O2S
(E)-3-(4-((4-Methylstyryl)sulfonyl)piperazin-1-yl)-6-(1H-1,2,4-triazol-1-yl)pyridazine chemical structure, C19H21N7O2S, CAS 1798414-35-3
(E)-3-(4-((4-Methylstyryl)sulfonyl)piperazin-1-yl)-6-(1H-1,2,4-triazol-1-yl)pyridazine
CAS 1798414-35-3C19H21N7O2S
(E)-4-(4-((4-Methylstyryl)sulfonyl)piperazin-1-yl)-6-(1H-1,2,4-triazol-1-yl)pyrimidine chemical structure, C19H21N7O2S, CAS 1799250-87-5
(E)-4-(4-((4-Methylstyryl)sulfonyl)piperazin-1-yl)-6-(1H-1,2,4-triazol-1-yl)pyrimidine
CAS 1799250-87-5C19H21N7O2S
3-[(1-{5,6-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}pyrrolidin-3-yl)(methyl)amino]-1,2-benzothiazole-1,1-dione chemical structure, C19H21N7O2S, CAS 2548983-20-4
3-[(1-{5,6-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}pyrrolidin-3-yl)(methyl)amino]-1,2-benzothiazole-1,1-dione
CAS 2548983-20-4C19H21N7O2S
3-[(1-{1,6-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}pyrrolidin-3-yl)(methyl)amino]-1,2-benzothiazole-1,1-dione chemical structure, C19H21N7O2S, CAS 2549052-68-6
3-[(1-{1,6-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}pyrrolidin-3-yl)(methyl)amino]-1,2-benzothiazole-1,1-dione
CAS 2549052-68-6C19H21N7O2S
3-[4-(1,6-Dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-1,4-diazepan-1-yl]-1,2-benzothiazole 1,1-dioxide chemical structure, C19H21N7O2S, CAS 2549039-15-6
3-[4-(1,6-Dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-1,4-diazepan-1-yl]-1,2-benzothiazole 1,1-dioxide
CAS 2549039-15-6C19H21N7O2S
3-(4-{5,6-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-1,4-diazepan-1-yl)-1??,2-benzothiazole-1,1-dione chemical structure, C19H21N7O2S, CAS 2549063-48-9
3-(4-{5,6-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-1,4-diazepan-1-yl)-1??,2-benzothiazole-1,1-dione
CAS 2549063-48-9C19H21N7O2S
N-Methyl-N-[1-(1-methylpyrazolo[5,4-d]pyrimidin-4-yl)piperidin-4-yl]-1,1-dioxo-1,2-benzothiazol-3-amine chemical structure, C19H21N7O2S, CAS 2549065-30-5
N-Methyl-N-[1-(1-methylpyrazolo[5,4-d]pyrimidin-4-yl)piperidin-4-yl]-1,1-dioxo-1,2-benzothiazol-3-amine
CAS 2549065-30-5C19H21N7O2S
3-{Methyl[1-(9-methyl-9H-purin-6-yl)piperidin-4-yl]amino}-1??,2-benzothiazole-1,1-dione chemical structure, C19H21N7O2S, CAS 2548986-52-1
3-{Methyl[1-(9-methyl-9H-purin-6-yl)piperidin-4-yl]amino}-1??,2-benzothiazole-1,1-dione
CAS 2548986-52-1C19H21N7O2S
N-[1-(3-Cyanopyrazin-2-yl)azetidin-3-yl]-2-{6,7-dimethyl-5-oxo-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-methylacetamide chemical structure, C19H21N7O2S, CAS 2380081-63-8
N-[1-(3-Cyanopyrazin-2-yl)azetidin-3-yl]-2-{6,7-dimethyl-5-oxo-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl}-N-methylacetamide
CAS 2380081-63-8C19H21N7O2S
2-Pyridinecarboxamide,N-[2-(dimethylamino)ethyl]-6-[[[[2-(4-pyridinyl)-4-thiazolyl]amino]carbonyl]amino]- chemical structure, C19H21N7O2S, CAS 400773-99-1
2-Pyridinecarboxamide,N-[2-(dimethylamino)ethyl]-6-[[[[2-(4-pyridinyl)-4-thiazolyl]amino]carbonyl]amino]-
CAS 400773-99-1C19H21N7O2S
4-{3-Phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-2-(thiomorpholine-4-carbonyl)morpholine chemical structure, C19H21N7O2S, CAS 2742033-65-2
4-{3-Phenyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-2-(thiomorpholine-4-carbonyl)morpholine
CAS 2742033-65-2C19H21N7O2S
4-Oxo-N-[(6-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-2,3,4a,5,6,7,8,8a-octahydro-1H-phthalazine-1-carboxamide chemical structure, C19H21N7O2S, CAS 1904211-83-1
4-Oxo-N-[(6-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-2,3,4a,5,6,7,8,8a-octahydro-1H-phthalazine-1-carboxamide
CAS 1904211-83-1C19H21N7O2S

Frequently asked questions

What is the molar mass of C19H21N7O2S?

The molar mass of C19H21N7O2S is 411.48 g/mol, calculated from standard atomic weights for 19 carbon atoms, 21 hydrogen atoms, 7 nitrogen atoms, 2 oxygen atoms and 1 sulfur atom. The monoisotopic mass is 411.1477 Da.

How many compounds have the formula C19H21N7O2S?

CompoundList lists 14 compounds with the molecular formula C19H21N7O2S, including GLS1 Inhibitor, 7-(2-((1H-Benzo[d]imidazol-2-yl)thio)ethyl)-3-methyl-8-(pyrrolidin-1-yl)-1H-purine-2,6(3H,7H)-dione, (E)-3-(4-((4-Methylstyryl)sulfonyl)piperazin-1-yl)-6-(1H-1,2,4-triazol-1-yl)pyridazine. Compounds that share a formula are isomers. They contain the same atoms arranged differently, so their properties, uses and prices can be very different.

What is the degree of unsaturation of C19H21N7O2S?

C19H21N7O2S has a degree of unsaturation of 13. That is the total number of rings and pi bonds (a double bond counts as one, a triple bond as two) in any structure with this formula.